Hyperliquid Strategies

PURR · NASDAQ

$9.15+$0.18 (+2.01%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $8.97

About PURR

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.

Employees: 0
Headquarters: New York City, New York
Listed: Dec 3, 2025
Sector: Health Care
Industry: Biotechnology

Leadership

Hyperliquid Strategies executives
Name	Title	Since	Age
Bob Diamond	—	2025	74
David Schamis	—	2025	51
Brett Beldner	—	—	54
Jeroen Nieuwkoop	—	—	54
Jeff Tuder	—	—	52
Nailesh Bhatt	—	—	53
Albert Dyrness	—	—	62
Thomas King	—	—	64
Larry Leibowitz	—	—	65
Eric Rosengren	—	—	68

Similar companies

Companies in the same industry as Hyperliquid Strategies

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.